RPRX — ROYALTY PHARMA PLC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 663 SEC-registered investment managers reported holding RPRX (ROYALTY PHARMA PLC) in their latest 13F filings, with a combined reported value of $21.40B across 393.17M shares. That is +6.5% by share count (+22.82M shares) versus the previous quarter, while reported value moved +21.5%. Ownership is concentrated: the five largest holders account for 37.1% of reported value and the top ten for 49.7%.
Compared with the prior quarter, 109 opened new positions, 294 added to existing stakes, 171 trimmed, 54 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of ROYALTY PHARMA PLC (RPRX) include Morgan Stanley, Capital International Investors, BlackRock Inc, ranked by reported 13F value among the 1014 institutional holders on this page.
RPRX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Legendary Investors Holding RPRX
The superinvestors we track who report RPRX in their latest 13F filing — each shown at that manager’s own most recent quarter.
| Investor | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
|
|
Q3 2026 | 3.42M | $199.71M | 6.75% | Reduce |
|
|
Q2 2026 | 2.46M | $137.74M | 8.82% | Add |
|
|
Q3 2026 | 564.46K | $32.94M | 4.47% | Reduce |
Which stocks do these investors own together? → · Embed this widget →
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 571 | 297.63M | $17.40B | +1.5% |
| Q2 2026 | 663 | 393.17M | $21.40B | +7.0% |
| Q1 2026 | 605 | 363.91M | $17.34B | -1.7% |
| Q4 2025 | 549 | 352.63M | $13.57B | +4.4% |
| Q3 2025 | 496 | 335.75M | $11.81B | -3.0% |
| Q2 2025 | 461 | 345.87M | $12.44B | -1.4% |
| Q1 2025 | 450 | 330.37M | $10.28B | -1.6% |
| Q4 2024 | 409 | 328.49M | $8.37B | +1.4% |
Over the 8 quarters shown, institutional share counts decreased 9% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2026 (+7.0%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 41.10M | $2.40B | 0.12% | Reduce | |
| 33.90M | $1.98B | 0.41% | Reduce | |
| 29.12M | $1.70B | 0.04% | Add | |
| 19.35M | $1.13B | 0.05% | Reduce | |
| 12.95M | $755.86M | 0.02% | Add | |
| 10.26M | $598.81M | 0.51% | Reduce | |
| 9.15M | $534.11M | 0.50% | Reduce | |
| 8.76M | $510.99M | 0.06% | Reduce | |
| 8.55M | $497.51M | 0.03% | Add | |
| 7.30M | $426.20M | 0.04% | Add | |
| 6.32M | $368.56M | 0.21% | Add | |
| 5.97M | $348.63M | 0.64% | Add | |
| 5.40M | $315.24M | 0.01% | Add | |
| 4.44M | $258.73M | 0.20% | Add | |
| 3.57M | $208.53M | 0.05% | Reduce | |
| 2.99M | $201.71M | 0.05% | Add | |
| 3.42M | $199.71M | 6.75% | Reduce | |
| 2.83M | $165.27M | 0.07% | Add | |
| 2.67M | $155.39M | 0.18% | Add | |
| 2.60M | $151.83M | 0.01% | Add | |
| 2.58M | $150.37M | 0.05% | Reduce | |
| 2.47M | $144.37M | 0.03% | Add | |
| 1.79M | $104.33M | 0.04% | Reduce | |
| 1.74M | $101.76M | 0.20% | Add | |
| 1.66M | $96.68M | 2.46% | Hold |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 42.93M | $2.41B | 0.13% | Reduce | |
| 35.27M | $1.98B | 0.41% | Add | |
| 27.83M | $1.56B | 0.04% | Add | |
| 24.51M | $1.37B | 0.06% | Reduce | |
| 11.19M | $627.63M | 0.06% | Add | |
| 10.73M | $601.44M | 0.52% | Reduce | |
| 10.02M | $561.57M | 0.51% | Reduce | |
| 9.52M | $533.64M | 0.07% | Add | |
| 9.52M | $533.64M | 0.06% | Add | |
| 8.06M | $450.58M | 0.02% | New | |
| 8.06M | $450.58M | 0.02% | Add | |
| 5.78M | $323.85M | 11.05% | Reduce | |
| 5.34M | $299.19M | 0.03% | Add | |
| 4.83M | $270.63M | 0.01% | Add | |
| 4.72M | $264.59M | 0.03% | Add | |
| 4.32M | $242.20M | 0.45% | Add | |
| 4.31M | $241.40M | 0.08% | Add | |
| 4.31M | $241.40M | 0.08% | Add | |
| 4.23M | $237.32M | 0.02% | Add | |
| 4.15M | $232.66M | 0.01% | Add | |
| 3.80M | $213.09M | 0.04% | Add | |
| 3.72M | $208.80M | 0.05% | Add | |
| 3.68M | $206.50M | 0.12% | Reduce | |
| 3.60M | $201.79M | 6.75% | Reduce | |
| 3.14M | $176.25M | 0.07% | Add |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 43.57M | $2.09B | 0.13% | Reduce | |
| 35.01M | $1.68B | 0.40% | Add | |
| 25.91M | $1.24B | 0.04% | Reduce | |
| 25.15M | $1.21B | 0.07% | Reduce | |
| 16.16M | $774.99M | 0.79% | Reduce | |
| 11.59M | $555.81M | 0.58% | Reduce | |
| 10.99M | $527.18M | 0.02% | Add | |
| 8.04M | $385.52M | 0.05% | New | |
| 8.04M | $385.52M | 0.05% | New | |
| 7.87M | $376.52M | 0.02% | Add | |
| 7.48M | $358.85M | 0.56% | Reduce | |
| 7.17M | $343.87M | 10.00% | Reduce | |
| 4.53M | $217.39M | 0.01% | New | |
| 3.85M | $184.87M | 0.12% | Reduce | |
| 3.81M | $182.71M | 0.02% | Reduce | |
| 3.81M | $182.69M | 0.38% | Add | |
| 3.75M | $180.00M | 0.02% | Add | |
| 3.78M | $179.65M | 0.08% | Add | |
| 3.78M | $179.65M | 0.08% | Add | |
| 3.64M | $174.79M | 6.56% | Add | |
| 3.50M | $167.70M | 0.01% | Add | |
| 3.36M | $161.32M | 0.04% | Add | |
| 3.10M | $148.50M | 0.03% | Reduce | |
| 3.09M | $148.17M | 0.04% | Add | |
| 3.03M | $145.25M | 0.02% | Add |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 55.27M | $2.14B | 0.13% | Add | |
| 31.10M | $1.20B | 0.19% | Add | |
| 26.27M | $1.02B | 0.05% | Reduce | |
| 26.19M | $1.01B | 0.03% | Hold | |
| 17.01M | $657.22M | 0.55% | Reduce | |
| 11.94M | $461.44M | 0.45% | Reduce | |
| 11.74M | $453.66M | 0.69% | Reduce | |
| 10.65M | $411.50M | 0.01% | Add | |
| 9.93M | $383.87M | 0.01% | Reduce | |
| 7.72M | $297.47M | 0.02% | Add | |
| 7.38M | $285.05M | 5.46% | Reduce | |
| 5.11M | $197.33M | 0.11% | Add | |
| 4.00M | $154.69M | 0.02% | Reduce | |
| 3.41M | $131.92M | 0.01% | Reduce | |
| 3.33M | $128.81M | 4.97% | Add | |
| 3.31M | $128.02M | 0.07% | Add | |
| 3.12M | $120.51M | 0.03% | Hold | |
| 3.09M | $119.32M | 0.03% | Add | |
| 2.93M | $113.17M | 5.21% | Hold | |
| 2.91M | $112.57M | 0.02% | Reduce | |
| 2.91M | $112.57M | 0.02% | Reduce | |
| 2.71M | $104.67M | 0.01% | Add | |
| 2.68M | $103.53M | 0.03% | Add | |
| 2.64M | $102.04M | 5.88% | Add | |
| 2.56M | $99.06M | 0.05% | Add |
Q3 2025 — 25 funds
Q2 2025 — 25 funds
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 8.06M sh · $450.58M
- Sixth Street Partners Management Company, L.P. 3.08M sh · $172.89M
- National Pension Service 707.18K sh · $39.65M
- BARROW HANLEY MEWHINNEY & STRAUSS LLC 267.55K sh · $15.00M
- PANAGORA ASSET MANAGEMENT INC 240.18K sh · $13.47M
- Bridgewater Associates 219.69K sh · $12.32M
- CANADA LIFE ASSURANCE Co 185.32K sh · $10.37M
- Triasima Portfolio Management inc. 180.71K sh · $10.13M
- Kepler Cheuvreux (Suisse) SA 160.34K sh · $8.99M
- LYNWOOD PRICE CAPITAL MANAGEMENT LP 143.00K sh · $8.02M
- Swiss Life Asset Management Ltd 136.28K sh · $7.64M
- BANK OF MONTREAL /CAN/ 130.88K sh · $7.34M
Fully Exited (vs previous quarter)
- STATE STREET CORP sold 10.99M sh · $527.18M
- Pacer Advisors, Inc. sold 689.19K sh · $33.06M
- Farallon Capital Management sold 493.00K sh · $23.65M
- FARALLON CAPITAL MANAGEMENT, L.L.C. sold 493.00K sh · $23.65M
- HRT FINANCIAL LP sold 202.85K sh · $9.73M
- Alyeska Investment Group, L.P. sold 150.43K sh · $7.22M
- Taproot Management LP sold 129.59K sh · $6.22M
- ExodusPoint Capital Management, LP sold 123.56K sh · $5.93M
- IEQ CAPITAL, LLC sold 104.78K sh · $5.03M
- Y-Intercept (Hong Kong) Ltd sold 73.34K sh · $3.52M
- Jain Global LLC sold 66.35K sh · $3.18M
- Mn Services Vermogensbeheer B.V. sold 58.60K sh · $2.81M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Morgan Stanley | 41.10M | 42.93M | 43.57M | 55.27M | 44.16M | 46.60M | 41.03M | 39.53M | 41.08M | 44.13M | 44.22M | 46.35M | 48.13M | 47.43M | 47.35M | 49.25M | 50.19M | 51.54M | 53.54M | 56.23M |
| Capital International Investors | 33.90M | 35.27M | 35.01M | 31.10M | 27.21M | 21.88M | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BlackRock Inc | 29.12M | 27.83M | 25.91M | 26.19M | 26.20M | 25.43M | 24.56M | 25.45M | 22.30M | — | — | — | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | 19.35M | 24.51M | 25.15M | 26.27M | 27.99M | 40.36M | 39.40M | 26.38M | 27.89M | 27.89M | 33.63M | 31.58M | 30.43M | 33.88M | 39.98M | 44.11M | 42.96M | 35.95M | 28.21M | 22.08M |
| STATE STREET CORP | 12.95M | — | 10.99M | 10.65M | 10.27M | 10.19M | 9.52M | 9.76M | 9.52M | 9.49M | 9.10M | 8.87M | 8.43M | — | — | — | — | — | — | — |
| Swedbank AB | 10.26M | 10.73M | 11.59M | 11.94M | 12.20M | 12.16M | 12.16M | 12.16M | 11.03M | 10.81M | — | 5.47M | 3.95M | — | — | — | — | — | — | — |
| Baillie Gifford & Co | 9.15M | 10.02M | 16.16M | 17.01M | 17.37M | 18.02M | 13.40M | 14.13M | 16.12M | 16.35M | 16.66M | 17.59M | 18.24M | 18.50M | 18.92M | 17.12M | 17.87M | 17.99M | 1.13M | — |
| Capital World Investors | 8.76M | 9.52M | 8.04M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 8.55M | 8.06M | 7.87M | 7.72M | 7.62M | 8.18M | 8.00M | 7.31M | 7.27M | 6.85M | 6.55M | 6.37M | 6.10M | 6.15M | 5.99M | 5.83M | 5.27M | 5.05M | 5.01M | 5.30M |
| Invesco Ltd | 7.30M | 4.23M | 3.75M | 1.50M | 1.59M | 1.56M | 1.28M | 957.89K | 719.38K | 1.74M | 673.69K | 656.86K | 610.01K | 689.95K | 713.17K | 2.88M | 3.13M | 2.65M | 683.37K | 543.60K |
| VICTORY CAPITAL MANAGEMENT INC | 6.32M | 3.68M | 3.85M | 5.11M | 4.66M | 4.49M | 3.62M | 978.21K | 849.03K | 669.62K | 458.49K | 265.71K | 338.89K | — | — | — | — | — | — | — |
| ROYAL LONDON ASSET MANAGEMENT LTD | 5.97M | 4.32M | 3.81M | 179.68K | 178.47K | 178.47K | 181.54K | 177.69K | 160.18K | 155.88K | 339.56K | 321.80K | 318.51K | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 5.40M | 4.83M | 4.53M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| NORDEA INVESTMENT MANAGEMENT AB | 4.44M | 2.58M | 788.02K | 812.66K | 776.00K | 656.00K | 93.20K | 27.79K | 579.02K | 24.64K | 24.64K | 22.67K | 22.67K | — | — | — | — | — | — | — |
| Amundi US | 3.57M | 3.72M | 3.09M | 2.68M | 2.07M | 2.80M | 1.24M | 2.55M | 3.69M | 2.06M | 2.21M | 3.69M | 1.61M | 1.37M | 1.03M | 990.28K | 829.61K | 936.57K | 299.98K | 199.72K |
| Franklin Resources | 2.99M | 2.01M | 1.72M | 677.48K | 788.02K | 934.22K | 782.97K | 539.48K | 1.46M | 1.39M | 1.23M | 96.36K | 70.64K | 53.99K | 40.72K | 41.80K | 26.10K | 134.05K | 130.57K | 129.78K |
| Patient Capital Management, LLC | 3.42M | 3.60M | 3.64M | 3.33M | 3.12M | 2.99M | 2.97M | 2.88M | 2.04M | 1.42M | 1.42M | 1.25M | — | — | — | — | — | — | — | — |
| Arrowstreet Capital | 2.83M | 2.44M | 2.01M | 3.31M | 3.28M | 2.98M | 1.36M | 669.88K | 1.39M | 940.03K | 882.75K | 1.78M | 1.95M | 1.91M | 1.96M | 2.50M | 1.92M | 1.06M | 592.48K | — |
| DekaBank Deutsche Girozentrale | 2.67M | 746.29K | 746.29K | 746.29K | 746.29K | 746.29K | 749.34K | 746.29K | 746.29K | 729.13K | 749.34K | 472.80K | 479.62K | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.60M | 2.46M | 2.27M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold RPRX?
As of 2026-Q2, 663 institutional funds reported holding RPRX (ROYALTY PHARMA PLC) in SEC 13F filings, with a combined reported value of $21.40B.
How many shares of RPRX do institutions own?
13F filers reported 393.17M shares of RPRX, worth $21.40B in aggregate at the end of 2026-Q2.
Is institutional ownership of RPRX rising or falling?
Share counts moved +6.5% versus the prior quarter — accumulation.
Who are the top institutional holders of RPRX?
The largest 13F holders are Morgan Stanley, Capital International Investors, BlackRock Inc, Fidelity Management & Research (FMR), STATE STREET CORP; the top 25 are ranked at the top of this page.
Who are the major shareholders of ROYALTY PHARMA PLC?
The major shareholders of ROYALTY PHARMA PLC (RPRX) by reported 13F value are Morgan Stanley, Capital International Investors, BlackRock Inc, Fidelity Management & Research (FMR), STATE STREET CORP, among 1014 institutional holders.
Which legendary investors own RPRX?
3 of the legendary investors tracked on HoldingsHub report RPRX (ROYALTY PHARMA PLC) in their latest 13F filings, led by Samantha McLemore, Pat Dorsey, Torray Funds. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on RPRX?
3 tracked superinvestors hold RPRX simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.